Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-27

Clinical Trial Update: Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing abrupt versus tapered interruption of chronic clopidogrel therapy after drug-eluting stent implantation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED